CANOCTAKIN
UNII MU4128F2CO

Substance Identification & Data

This profile provides standardized clinical and technical data for Canoctakin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MU4128F2CO.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1019859-03-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
MU4128F2CO
CAS Registry Number
1019859-03-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CANOCTAKIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C174723
National Cancer Institute reference terminology for clinical and research data.
INN ID
9125
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Canoctakin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CANOCTAKIN

Common Names & Synonyms

CANOCTAKIN [INN]
GLYCAFILIN
PA401
PA-401
RECOMBINANT DNA DERIVED, HUMAN INTERLEUKIN 8 (CXCL8) MUTEIN, PRODUCED IN ESCHERICHIA COLI: (44,48,97,98-TETRA-L-LYSINE)HUMAN INTERLEUKIN 8 PRECURSOR-(34-99)- PEPTIDE ANTI-INFLAMMATORY

Systematic Nomenclature

INTERLEUKIN 8 (SYNTHETIC HUMAN CLONE DNCXCL8 INCREASED-GLYCOSAMINOGLYCAN BINDING ISOFORM PA401)

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus